FDA Warning Letter — Lernapharm (Loris) Inc.
The FDA took a Warning Letter action against Lernapharm (Loris) Inc. on September 4, 2018 (Saint-Laurent, Canada). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Lernapharm (Loris) Inc.
- Date
- September 4, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Saint-Laurent (Canada)